Risk factors for progression in patients with KDOQI stage 3 Chronic Kidney Disease (PROGRESER study) Alberto Martínez-Castelao; José Luis Górriz Teruel; Luis D¿Marco; Enrique Garrigós; Gema Fernández-Fresnedo; Eugenia Espinel Garuz; Secundino Cigarrán Guldris; Jesús Arteaga Coloma; Nicolas Roberto Robles Pérez-Monteoliva; José Rafael Esteban de la Rosa; Luis Javier Nieto Iglesias; Alberto Ortiz Arduán; Juan Francisco Navarro-González;

Recommendations for the evaluation and treatment of patients with diabetes and albuminuria. Role of non-steroidal mineralocorticoid antagonism Juan Payán López; Pedro Chinchurreta Capote; Antonio Hormigo Pozo; Luis Castilla-Guerra; José Carlos Fernández-García; Rosa Fernández Olmo; María José Espigares Huete;

Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease Mariana Morais David Pliças; Bernardo Marques da Silva; Edgar Avito Fernandes de Almeida;